Skip to content
PICO Portalanswers from OpenAlex

Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group

PaperCitations, authors & open-access status

Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group is a paper indexed in PICO Portal from OpenAlex.

How many citations does Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group have?

PICO Portalcitation count

Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group has 49 citations in the OpenAlex counts PICO Portal stores.

When was Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group published?

PICO Portalyear

Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group has 2023 year in the PICO Portal index.

What is the open-access status of Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group?

PICO Portaloa status

Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group has gold oa status in the PICO Portal index.

What is the DOI of Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group?

PICO Portaldoi

The DOI for Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group is on the source record.

What is the PMID of Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group?

PICO Portalpmid

The PMID for Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group is on the source record.

What is the OpenAlex record for Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group?

PICO Portalopenalex

The OpenAlex for Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial